Prediction of Preeclampsia & Other Obstetric Complications by Serum Homocysteine & Doppler

NCT02541110 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2015-09-04

No results posted yet for this study

Summary

Second trimester homocysteine \& uterine artery doppler will be assessed\& the cases will be followed up till delivery for development of preeclampsia, IUGR(intra-uterine growth retardation) \& other obstetric complications.

Conditions

Sponsors & Collaborators

  • Kasr El Aini Hospital

    lead OTHER

Principal Investigators

  • suzy abdelaziz, M.D. · kasrelaini hospital

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2016-01-31
Completion
2016-02-29

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02541110 on ClinicalTrials.gov